PLK1 and colorectal carcinoma: Higher levels of PLK-1/phosphorylated-PLK1 were found in relapsed/mCRC tissues compared to matched primary CRC tissues, suggesting that it is a marker of poor prognosis and resistance to oxaliplatin-based chemotherapy [139].